Departments of Urology, Affiliated Jiang-yin Hospital of the Southeast University Medical College, Jiang-yin, 214400, China.
World J Surg Oncol. 2018 Jul 3;16(1):124. doi: 10.1186/s12957-018-1433-3.
Although numerous studies have shown that positive surgical margin (PSM) is linked to biochemical recurrence (BCR) in prostate cancer (PCa), the research results have been inconsistent. This study aimed to explore the association between PSM and BCR in patients with PCa following radical prostatectomy (RP).
In accordance with the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), PubMed, EMBASE and Wan Fang databases were searched for eligible studies from inception to November 2017. The Newcastle-Ottawa Scale was used to assess the risk of bias of the included studies. Meta-analysis was performed by using Stata 12.0. Combined hazard ratios (HRs) and their corresponding 95% confidence intervals (CIs) were calculated using random-effects or fixed-effects models.
Ultimately, 41 retrospective cohort studies of high quality that met the eligibility criteria, comprising 37,928 patients (94-3294 per study), were included in this meta-analysis. The results showed that PSM was associated with higher BCR risk in both univariate analysis (pooled HR = 1.56; 95% CI 1.46, 1.66; p < 0.001) and multivariate analysis (pooled HR = 1.35; 95% CI 1.27, 1.43; p < 0.001). Moreover, no potential publication bias was observed among the included studies in univariate analysis (p-Begg = 0.971) and multivariate analysis (p-Begg = 0.401).
Our meta-analysis demonstrated that PSM is associated with a higher risk of BCR in PCa following RP and could serve as an independent prognostic factor in patients with PCa.
尽管大量研究表明,前列腺癌(PCa)根治性前列腺切除术后(RP)的阳性切缘(PSM)与生化复发(BCR)相关,但研究结果并不一致。本研究旨在探讨 RP 后 PCa 患者 PSM 与 BCR 的关系。
根据系统评价和荟萃分析的首选报告项目(PRISMA)指南,从建库到 2017 年 11 月,检索了 PubMed、EMBASE 和万方数据库中符合条件的研究。采用纽卡斯尔-渥太华量表评估纳入研究的偏倚风险。使用 Stata 12.0 进行 Meta 分析,采用随机效应或固定效应模型计算合并的危险比(HR)及其相应的 95%置信区间(CI)。
最终纳入了 41 项高质量的回顾性队列研究,共纳入 37928 例患者(每例研究 94-3294 例),符合本 Meta 分析的纳入标准。结果显示,单因素分析(合并 HR=1.56;95%CI 1.46,1.66;p<0.001)和多因素分析(合并 HR=1.35;95%CI 1.27,1.43;p<0.001)均表明 PSM 与更高的 BCR 风险相关。此外,单因素分析(p-Begg=0.971)和多因素分析(p-Begg=0.401)中均未观察到纳入研究的潜在发表偏倚。
本 Meta 分析表明,PSM 与 RP 后 PCa 的 BCR 风险升高相关,可作为 PCa 患者的独立预后因素。